Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
- Conditions
- Cancer
- Registration Number
- NCT01148407
- Lead Sponsor
- University of Vermont
- Brief Summary
Blood samples on persons with cancer will be sampled for angiogenic, metastatic and coagulation proteins.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Patients with a diagnosis of malignancy
Read More
Exclusion Criteria
- Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Vermont/Fletcher Allen Health Care
🇺🇸Burlington, Vermont, United States